Cellular Biomedicine Group Inc. announced the appointment of Dr. Xia Meng as Chief Operating Officer for the Company. Dr. Xia Meng has over 18 years of broad experience in biopharmaceutical and biotechnological industries, from research & development and product development to marketing, sales, business and management, both in domestic and international companies. She worked previously as General Manager of Transgene Tasly (Tianjin) Biopharmaceutical Co. Ltd., and Transgene Biopharmaceutical Technology (Shanghai) Co. Ltd., Asia Pacific Scientific Director, Global Oncology Program Director, Asia Pacific Regional Business Manager of bioMérieux and Head of Fudan University Shanghai Cancer Center - Institute Mérieux Laboratory.